National University Health System Launches NUGEM Centre to Revolutionize Precision Medicine and Genomic Testing

NUHS opens the National University Centre for Genomic Medicine to expand genetic testing, improve drug safety, and personalize treatments across Singapore.

By: AXL Media

Published: Apr 2, 2026, 7:16 AM EDT

Source: Information for this report was sourced from The Straits Times

Inaugurating a New Era of Precision Healthcare

The National University Health System has formally established the National University Centre for Genomic Medicine, marking a significant transition toward systematic precision medicine in Singapore. Launched on April 2, the center is designed to consolidate genomic expertise that was previously fragmented across various medical silos. According to Associate Professor Ng Kar Hui, the director of NUGEM, the facility will provide a centralized hub within the National University Hospital to bring molecular biology closer to the patient bedside. By integrating specialists from the National University Cancer Institute and the National University Heart Centre, the initiative seeks to make genetic profiling a standard component of long term healthcare delivery.

Broadening the Scope of Genetic Diagnostic Capabilities

While genomic testing was historically reserved for rare pediatric conditions, the new center is set to expand these services to a wider adult demographic. The facility includes a dedicated genomics laboratory that allows for in house testing, which facilitates faster collaboration on complex undiagnosed cases. According to center officials, NUGEM will also support researchers from the National University of Singapore in developing novel diagnostic tools for patients with ambiguous genetic results. This shift represents a move toward preventive health, where the mapping of a patient's genome can identify predispositions to chronic illnesses before symptoms manifest, significantly altering the traditional reactive model of medicine.

Optimizing Treatment Through Advanced Pharmacogenomics

A primary technical focus of the new center is the advancement of pharmacogenomics, which involves tailoring medication choices based on an individual's unique genetic profile. By analyzing how specific genetic variants influence drug metabolism, clinicians can prescribe dosages that are both safer and more effective. To date, over 2,000 patients within the National University Health System have undergone this specialized testing, with plans currently underway to scale these operations for population level use. This methodology reduces the risks of adverse drug reactions and ensures that pharmaceutical interventions are optimized for each patient's biological makeup, thereby improving overall recovery rates and clinical...